HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 210 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $409,119 | +10.1% | 10,057 | 0.0% | 0.01% | +25.0% |
| Q4 2023 | $371,707 | -51.2% | 10,057 | -24.8% | 0.01% | -52.9% |
| Q4 2022 | $762,000 | +26.6% | 13,371 | -12.1% | 0.02% | 0.0% |
| Q3 2022 | $602,000 | -9.2% | 15,212 | +1.0% | 0.02% | 0.0% |
| Q2 2022 | $663,000 | -15.6% | 15,061 | -67.1% | 0.02% | +750.0% |
| Q2 2019 | $786,000 | +6.6% | 45,778 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $737,000 | +10.0% | 45,778 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $670,000 | -19.5% | 45,778 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $832,000 | +128.6% | 45,778 | +112.4% | 0.00% | +100.0% |
| Q2 2018 | $364,000 | -6.7% | 21,550 | +8.3% | 0.00% | 0.0% |
| Q1 2018 | $390,000 | – | 19,906 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $206,177,000 | 28.12% |
| BB BIOTECH AG | 8,322,860 | $121,763,000 | 3.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 398,633 | $4,579,000 | 2.84% |
| DOHENY ASSET MANAGEMENT /CA | 227,193 | $3,324,000 | 2.43% |
| SNYDER CAPITAL MANAGEMENT L P | 2,833,759 | $41,458,000 | 2.24% |
| First Light Asset Management, LLC | 938,399 | $13,729,000 | 2.19% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,027,164 | $132,067,000 | 1.77% |
| Taylor Wealth Management Partners | 204,277 | $2,989,000 | 1.72% |
| Sterling Global Strategies LLC | 22,000 | $321,860,000 | 1.63% |
| Granite Investment Partners, LLC | 988,939 | $14,468,000 | 1.06% |